Alex Gorsky, who has led Johnson & Johnson for nearly a decade, will step away from his role at the start of 2022 due to health issues. He will be succeeded as executive chairman by Joaquin Duato, who most recently served as J&J’s COVID-19 czar. (Endpoints News)
An Associated Press/NORC Center for Public Affairs Research poll revealed that pandemic anxiety in the U.S. is at its highest level since winter. The poll also found that a majority of Americans are in favor of vaccination mandates for airplane travel, concert attendance and more. (AP)
AstraZeneca announced that, in a late-stage trial, its new antibody therapy reduced the risk of recipients developing COVID-19 symptoms by 77%. The therapy, AZD7442, consists of lab-made antibodies. (Reuters)
Even as the number of children infected with COVID-19 surges, most schools remain reluctant to offer on-site vaccination. President Biden recently called for schools to set up pop-up clinics. (The New York Times)
Healthcare workers sent to COVID-19 hotspots characterized the current cycle of the pandemic as “soul-draining.” Many expressed frustration with the number of unvaccinated people they are treating. (STAT)
